ALK-Abelló, headquartered in Hørsholm, Denmark, is a research-driven pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
| Website | http://www.alk.net |
| Ticker | AKABY |
| Revenue | $749.8 million |
| Employees | View employees |
| Founded | 1923 |
| Address | 6-8 Bøge Allé, Hoersholm DK-2970, DK |
| Phone | +1 512-251-0037 |
| Fax | (454) 574-8690 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+94 more
(view full list)
|
| Industry | Pharmaceuticals, Health Diagnostics, Healthcare, Health Care, Medical, Pharmaceutical |
| Web Rank | 5 Million |
| Keywords | Alk Abello Pipeline, Incentivize Board Of Directors, Alk-Abello B |
| Competitors | Merck & Co., Inc., Sanofi, GSK, アステラス製薬(株), Actavis plc (now Allergan), Novartis, Boehringer Ingelheim, Pfizer, Roche, AbbVie +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 44 Companies |
Looking for a particular ALK-Abello Ltd. employee's phone or email?
The ALK-Abello Ltd. annual revenue was $749.8 million in 2026.
The NAICS codes for ALK-Abello Ltd. are [54, 54171, 5417, 541, 541711, 44].
The SIC codes for ALK-Abello Ltd. are [28, 80, 283].